Report Highlights
Including: 1) By Products: Companion Diagnostics; Molecular Diagnostics
2) By End-User: Cancer Research Institutes; Diagnostic Laboratories; Hospitals
3) By Method: Biopsy; Endoscopy; Tumor Biomarker Tests; Imaging
4) By Application: Cervical Cancer; Breast Cancer; Liver Cancer; Blood Cancer; Kidney Cancer; Colorectal Cancer; Pancreatic Cancer; Ovarian Cancer; Melanoma
Covering: Abbott; Becton Dickinson and Company; Hoffmann-La Roche Ltd.; GE Healthcare Ltd.; Thermo Fisher Scientific
Cancer Diagnostics Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description:
Where is the largest and fastest growing market for cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Report Synopsis
| Report Metrics | Details |
| Base year considered | 2022 |
| Forecast period considered | 2022-2032 |
| Units considered | $ Billion |
| Segments covered | By Products, By End-User, By Method, By Application |
| Industry covered | Medical Equipment |
| Regions covered | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Countries covered | Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA |
| Companies studied |
|
Scope
Markets Covered:
- By Products: Companion Diagnostics; Molecular Diagnostics
- By End-User: Cancer Research Institutes; Diagnostic Laboratories; Hospitals; Other End Users
- By Method: Biopsy; Endoscopy; Tumor Biomarker Tests; Imaging
- By Application: Cervical Cancer; Breast Cancer; Liver Cancer; Blood Cancer; Kidney Cancer; Colorectal Cancer; Pancreatic Cancer; Ovarian Cancer; Melanoma; Other Applications
Companies Mentioned: Abbott; Becton Dickinson and Company; Hoffmann-La Roche Ltd.; GE Healthcare Ltd.; Thermo Fisher Scientific
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
- Table 1 : Global Historic Market Growth, 2017-2022, $ Billion
- Table 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
- Table 3 : Global Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 4 : Global Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 5 : Global Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 6 : Global Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 7 : Global Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 8 : Global Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 9 : Asia-Pacific, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 10 : Asia-Pacific, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 11 : Asia-Pacific, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 12 : China, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 13 : China, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 14 : China, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 15 : India, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 16 : India, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 17 : India, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 18 : Japan, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 19 : Japan, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 20 : Japan, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 21 : Australia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 22 : Australia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 23 : Australia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 24 : Indonesia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 25 : Indonesia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 26 : Indonesia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 27 : South Korea, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 28 : South Korea, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 29 : South Korea, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 30 : Western Europe, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 31 : Western Europe, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 32 : Western Europe, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 33 : UK, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 34 : UK, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 35 : UK, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 36 : Germany, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 37 : Germany, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 38 : Germany, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 39 : France, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 40 : France, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 41 : France, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 42 : Eastern Europe, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 43 : Eastern Europe, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 44 : Eastern Europe, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 45 : Russia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 46 : Russia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 47 : Russia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 48 : North America, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 49 : North America, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 50 : North America, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 51 : USA, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 52 : USA, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 53 : USA, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 54 : South America, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 55 : South America, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 56 : South America, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 57 : Brazil, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 58 : Brazil, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 59 : Brazil, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 60 : Middle East, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 61 : Middle East, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 62 : Middle East, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 63 : Africa, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 64 : Africa, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 65 : Africa, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 66 : Abbott Financial Performance
- Table 67 : Becton Dickinson and Company Financial Performance
- Table 68 : Hoffmann-La Roche Ltd Financial Performance
- Table 69 : GE Healthcare Ltd. Financial Performance
- Table 70 : Thermo Fisher Scientific Financial Performance
- Figure 1 : Global Historic Market Growth, 2017-2022, $ Billion
- Figure 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
- Figure 3 : Global Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 4 : Global Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 5 : Global Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 6 : Global Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 7 : Global Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 8 : Global Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 9 : Asia-Pacific, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 10 : Asia-Pacific, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 11 : Asia-Pacific, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 12 : China, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 13 : China, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 14 : China, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 15 : India, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 16 : India, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 17 : India, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 18 : Japan, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 19 : Japan, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 20 : Japan, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 21 : Australia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 22 : Australia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 23 : Australia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 24 : Indonesia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 25 : Indonesia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 26 : Indonesia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 27 : South Korea, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 28 : South Korea, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 29 : South Korea, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 30 : Western Europe, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 31 : Western Europe, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 32 : Western Europe, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 33 : UK, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 34 : UK, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 35 : UK, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 36 : Germany, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 37 : Germany, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 38 : Germany, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 39 : France, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 40 : France, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 41 : France, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 42 : Eastern Europe, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 43 : Eastern Europe, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 44 : Eastern Europe, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 45 : Russia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 46 : Russia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 47 : Russia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 48 : North America, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 49 : North America, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 50 : North America, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 51 : USA, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 52 : USA, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 53 : USA, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 54 : South America, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 55 : South America, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 56 : South America, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 57 : Brazil, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 58 : Brazil, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 59 : Brazil, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 60 : Middle East, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 61 : Middle East, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 62 : Middle East, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 63 : Africa, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 64 : Africa, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 65 : Africa, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 66 : Abbott Financial Performance
- Figure 67 : Becton Dickinson and Company Financial Performance
- Figure 68 : Hoffmann-La Roche Ltd Financial Performance
- Figure 69 : GE Healthcare Ltd. Financial Performance
- Figure 70 : Thermo Fisher Scientific Financial Performance
The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Similar Reports from TBRC (Publisher)
Cancer Diagnostics Global Market Report 2022
Including: 1) By Products: Companion Diagnostics; Molecular Diagnostics
2) By End-User: Cancer Research Institutes; Diagnostic Laboratories; Hospitals; Other End Users
3) By Method: Biopsy; Endoscopy; Tumor Biomarker Tests; Imaging
4) By Application: Cervical Cancer; Breast Cancer; Liver Cancer; Blood Cancer; Kidney Cancer; Colorectal Cancer; Pancreatic Cancer; Ovarian Cancer; Melanoma; Other Applications
Covering: Abbott; Becton Dickinson and Company; ...
Cancer Diagnostics Global Market Report 2021: COVID-19 Growth And Change To 2030
Including: 1) By Products: Companion Diagnostics; Molecular Diagnostics
2) By End-User: Cancer Research Institutes; Diagnostic Laboratories; Hospitals; Others
3) By Method: Biopsy; Endoscopy; Tumor Biomarker Tests; Imaging
4) By Application: Cervical Cancer; Breast Cancer; Liver Cancer; Blood Cancer; Kidney Cancer; Colorectal Cancer; Pancreatic Cancer; Ovarian Cancer; Melanoma; Others
Covering: Abbott; Becton, Dickinson and Company; Hoffmann-La Roche ...
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More